TERO-PEKKA ALASTALO

M.D., Ph.D., Co-founder, President & Head of US Operations, 
Blueprint Genetics Inc.

Tero-Pekkahas previously been the Laboratory Director and Chief Medical Officer at Blueprint Genetics. He has also been in charge of developing diagnostic panels, mutation and knowledge databases, and clinical interpretation of genetic data. Tero-Pekka graduated from the University of Turku, Finland, in 2001 with an MD-PhD degree. His PhD thesis was done at the Turku Centre for Biotechnology in the area of molecular and cellular biology. After his graduation he did his 6-year clinical training in Pediatrics at the Turku University Hospital. In 2007 he continued basic research on cardiovascular diseases as a 3-year postdoctoral fellow at Stanford University, USA. After his postdoctoral training he has finished a 3-year clinical training in Pediatric Cardiology at University Hospital Helsinki and worked as a principal investigator in a research group focusing on molecular genetics of cardiovascular diseases.

 

OS-Seq Boosting Genetic Diagnostics

Blueprint Genetics’ sequencing and data-analysis innovations are establishing new standards in quality, speed and cost-effectiveness in genetic diagnostics. In 2016 we will launch OS-Seq –based genetic tests to all human genetic disorders to boost utilization of genetic data in the management of patients, family members, and screening of healthy populations.

Web Analytics